March 6, 2018 / 1:06 PM / 7 months ago

BRIEF-Boehringer Ingelheim And Lilly Expand Heart Failure Program For Jardiance

March 6 (Reuters) - Eli Lilly And Co:

* BOEHRINGER INGELHEIM AND LILLY EXPAND HEART FAILURE PROGRAM FOR JARDIANCE® WITH NEW EXERCISE CAPACITY TRIALS

* ELI LILLY AND CO - ‍EMPERIAL TRIALS TO EVALUATE EFFECT OF JARDIANCE ON EXERCISE ABILITY, HEART FAILURE SYMPTOMS IN PEOPLE WITH CHRONIC HEART FAILURE​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below